These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6988267)

  • 1. Effect of insulin treatment on prostacyclin in experimental diabetes.
    Harrison HE; Reece AH; Johnson M
    Diabetologia; 1980 Jan; 18(1):65-8. PubMed ID: 6988267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular prostacyclin release and metabolic derangement in diabetes.
    Harrison HE; Johnson M
    Horm Metab Res Suppl; 1981; 11():43-9. PubMed ID: 7033096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats.
    Valentovic MA; Lubawy WC
    Diabetes; 1983 Sep; 32(9):846-51. PubMed ID: 6354792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated glucose in vivo and in vitro adversely alters prostaglandin generation in rat aortas and platelets.
    Valentovic MA; Lubawy WC
    Prostaglandins Leukot Med; 1985 Sep; 19(3):271-7. PubMed ID: 3903777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin (PGI2) activity in rat kidney-stimulated by angiotensin II.
    Silberbauer K; Sinzinger H; Winter M
    Exp Mol Pathol; 1979 Apr; 30(2):242-54. PubMed ID: 369880
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of diabetic rat aorta to self-deactivation during prostacyclin synthesis.
    Kawamura K; Dohi T; Ogawa T; Shirakawa M; Okamoto H; Tsujimoto A
    Prostaglandins Leukot Med; 1987 Jun; 28(1):1-13. PubMed ID: 3112803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of furosemide on prostacyclin-like antiaggregatory release from vessel wall and renal cortex.
    Weithmann KU
    Pharmacol Res Commun; 1982 May; 14(5):391-9. PubMed ID: 7051051
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of insulin and prostacyclin production in the rat.
    Lasché EM; Larson RE
    Diabetes; 1982 May; 31(5 Pt 1):454-8. PubMed ID: 6759261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of experimentally induced diabetes on swine vascular prostacyclin (PGI2) synthesis.
    Silberbauer K; Clopath P; Sinzinger H; Schernthaner G
    Artery; 1980; 8(1):30-6. PubMed ID: 6448594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of experimental diabetes on prostacyclin production by tissues from pregnant rats.
    El Tahir KE; Williams KI; Betteridge DJ
    Prostaglandins Leukot Med; 1982 May; 8(5):429-35. PubMed ID: 7048333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented thromboxane generation by mesenteric arteries from pancreatectomized diabetic dogs is coincident with the vascular tone enhancement evoked by Na arachidonate and prostacyclin.
    Sterin-Borda L; Franchi AM; Borda ES; Del Castillo E; Gimeno MF; Gimeno AL
    Eur J Pharmacol; 1984 Aug; 103(3-4):211-21. PubMed ID: 6436040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of megavitamin E on prostacyclin and thromboxane synthesis in streptozotocin-induced diabetic rats.
    Gilbert VA; Zebrowski EJ; Chan AC
    Horm Metab Res; 1983 Jul; 15(7):320-5. PubMed ID: 6350138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of prostacyclin (PGI2) by the ductus arteriosus of fetal lambs at different stages of gestation.
    Clyman RI; Mauray F; Koerper MA; Wiemer F; Heymann MA; Rudolph AM
    Prostaglandins; 1978 Oct; 16(4):633-42. PubMed ID: 364551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin activity in rat kidney stimulated by angiotensin II.
    Silberbauer K; Sinzinger H; Winter M
    Br J Exp Pathol; 1979 Feb; 60(1):38-44. PubMed ID: 380621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats.
    Quyyumi AA; Iaffaldano R; Guerrero JL; Ryan CA; Powell WJ; Axelrod L
    Diabetes; 1989 Dec; 38(12):1585-94. PubMed ID: 2511053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin-like activity of endothelium and subendothelium - important for atherosclerosis?
    Silberbauer K; Sinzinger H; Winter M; Feigl W; Ring F
    Experientia; 1978 Nov; 34(11):1471-2. PubMed ID: 363442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prostacyclin release from perfused hearts of acutely diabetic rats.
    Rösen P; Schrör K
    Diabetologia; 1980 May; 18(5):391-4. PubMed ID: 7000593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased vascular prostacyclin in experimental diabetes.
    Harrison HE; Reece AH; Johnson M
    Life Sci; 1978 Jul; 23(4):351-5. PubMed ID: 357875
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of alpha-tocopherol on the development of diabetic angiopathy, platelet aggregation and status of the prostacyclin-thromboxane system in rats with streptozotocin diabetes].
    Zadkova GF; Avakian TIu; Markov KhM
    Probl Endokrinol (Mosk); 1993; 39(5):40-3. PubMed ID: 8108349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin treatment normalises the arachidonic acid induced prostacyclin release from the platelet perfused diabetic rat heart. Evidence for major changes in 15-hete production.
    Bresser HJ; Rösen P; Schrör K
    Prog Clin Biol Res; 1987; 242():143-8. PubMed ID: 3118378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.